logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9844535 B1

PDFFull Text
Date of Patent:
Dec. 19, 2017

Filed:

Jul. 02, 2014

Shp2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitors

Applicants:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);

Inventors:

Zhong-Yin Zhang, Carmel, IN (US);

Maria Kontaridis, Auburndale, MA (US);

Li-Fan Zeng, Indianapolis, IN (US);

Jianxun Wang, Cambridge, MA (US);

Assignee:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Attorney:

Stinson Leonard Street LLP

Primary Examiner:

San-Ming Hui

Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/4025 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61K 31/427 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 31/4025 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/433 (2013.01);
Abstract

Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).

Find Patent Forward Citations

Zhang, Zhong-Yin. (2017). Shp2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitors (U.S. Patent No. 9844535). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9844535

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…